SIVEXTRO (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the SIVEXTRO drug offered from Merck Sharp & Dohme Corp.. This Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient],Breast Cancer Resistance Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | tedizolid phosphate |
| SUBSTANCE NAME: | TEDIZOLID PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Oxazolidinone Antibacterial [EPC],Oxazolidinones [Chemical/Ingredient],Breast Cancer Resistance Protein Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-06-20 |
| END MARKETING DATE: | 0000-00-00 |
SIVEXTRO HUMAN PRESCRIPTION DRUG Details:
| Item Description | SIVEXTRO from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/4mL) |
| START MARKETING DATE: | 2014-06-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67919-040_8b71a547-6995-4f68-b44b-92b749bab1c1 |
| PRODUCT NDC: | 67919-040 |
| APPLICATION NUMBER: | NDA205436 |
Other TEDIZOLID PHOSPHATE Pharmaceutical Manufacturers / Labelers:
